Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Oct 3, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SeeMyLife clinical trial is studying the real-life experiences of children and teenagers with rare eye diseases that can lead to severe vision loss or blindness. The goal is to understand how these conditions affect their daily lives, emotional well-being, and social interactions. By using surveys and personal interviews, the trial aims to gather important information from both the young patients and their caregivers. This will help create better tools for measuring the quality of life for children with visual impairments, ultimately leading to improved care and support for them and their families.
To participate in this trial, children aged 8 to 18 with specific levels of visual impairment, as defined by the World Health Organization, and their parents or caregivers are eligible. Participants can expect to share their feelings and experiences related to their vision challenges through surveys and interviews. This research is crucial as it will not only enhance our understanding of the impact of these eye diseases but will also help develop more effective treatments and support systems tailored to the needs of these children and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children (age 8-12) and teenagers (age 13-18) with various levels of visual impairment defined according to World Health Organization (WHO) International Classification of Diseases (ICD) 10 - WHO ICD 10 \[best-corrected visual acuity ≤ 0.3 decimal or ≤ 6/18\], and their parents/caregivers.
- Exclusion Criteria:
- * Children, teenagers, and caregivers:
- • 1. who lack the ability to respond in a reliable way to the questions on how they feel about their visual impairment (patients with mild intellectual or cognitive deficiency may be able to reply accurately as opposed to cases with severe intellectual disability)
- • 2. with functional or non-ophthalmic reasons of visual impairment
- • 3. unable to provide consent/assent;
- • 4. who do not speak/read the language
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported